Literature DB >> 30579546

A Cautionary Analysis of Immunotherapy Prior to Targeted Therapy.

Caroline E McCoach1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30579546     DOI： 10.1016/j.jtho.2018.10.009

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

Review 1.  The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target-a narrative review.

Authors:  Alessia Spagnuolo; Paolo Maione; Cesare Gridelli
Journal:  Transl Lung Cancer Res       Date:  2022-06

Review 2.  Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR.

Authors:  Karan Seegobin; Umair Majeed; Nathaniel Wiest; Rami Manochakian; Yanyan Lou; Yujie Zhao
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244

3.  Clinical outcomes of Atezolizumab Therapy for Previously-Treated Advanced-Stage Non-Small Cell Lung Cancer: A Real-World Study in Taiwan.

Authors:  Shang-Gin Wu; Chi-Lu Chiang; Chin-Chou Wang; Jen-Yu Hung; Te-Chun Hsia; Chih-Hsi Kuo; Jin-Yuan Shih
Journal:  J Cancer       Date:  2022-07-18       Impact factor: 4.478
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.